Advertisement

Topics

NICE issues draft guidance backing Galafold for Fabry disease

17:23 EDT 19 Oct 2016 | thePharmaLetter

Amicus Therapeutics says that the National Institute for Health and Care Excellence (NICE) has issued…

Original Article: NICE issues draft guidance backing Galafold for Fabry disease

NEXT ARTICLE

More From BioPortfolio on "NICE issues draft guidance backing Galafold for Fabry disease"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...